NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Tirzepatide from BeiBangAn? Mail in a sample (US only) and let us test it.

Test my supply
+6 more ↓
76%
Finnrick rating
#198 of 281 Tirzepatide vendors
15 of 20 classifiable tests passed
customers 4.7★ (18)
methodology · Purity focus
Finnrick analysis · Tirzepatide

BeiBangAn's Tirzepatide rating is held down by fill volatility, not identity: recent labs include a -68% quantity result after a short pass streak. Purity is usually high, but 94.16% and 99.31% misses add evidence-quality caveats.

methodology →
vendor intelligence report
Vendor Intelligence Report: BeiBangAn

BBA’s public COA page now exists, but the certificate trail stops short of vial-level traceability. The report maps Hostinger staging fingerprints, LNpeptide build artifacts, lapsed domains, and Telegram copycat risk.

33 pages7 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.10
85%
5
2
Retatrutide
$0.70
78%
40
3
Tirzepatideselected
$0.34
76%
20
4
Semaglutide
$0.45
69%
4
5
PT-141
-
60%
3
6
BPC-157
$0.70
54%
4
8
Cagrilintide
$1.85
-
0
10
HGH
-
-
0
12
Melanotan II
$0.55
-
0
13
Sermorelin
$1.20
-
0
14
TB-500
$1.50
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%5 Dec 2025: 79%11 Dec 2025: 80%17 Dec 2025: 81%18 Dec 2025: 82%18 Dec 2025: 78%18 Dec 2025: 79%29 Dec 2025: 81%29 Dec 2025: 82%19 Jan 2026: 79%4 Feb 2026: 79%15 Feb 2026: 81%20 Feb 2026: 76%20 Feb 2026: 77%26 Feb 2026: 78%26 Feb 2026: 75%13 Jul 2026: 77%21 Jul 2026: 78%4 Aug 2026: 79%18 Aug 2026: 79%28 Oct 2026: 76%15 Nov 2026: current 76%79%77%76%Dec 25Nov 26
Showing Tirzepatide tests only
Peptide testing

Ordered Tirzepatide from BeiBangAn? Mail in a sample (US only) and let us test it.

Test my supply
BeiBangAn Tirzepatide test history
COA-backed lab tests
1-10 of 20

About BeiBangAn test results from Finnrick

BeiBangAn is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 77 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible BeiBangAn peptides in this dataset are BPC-157 (4 tests), GHK-Cu (5 tests) and PT-141 (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 77 recent tests. It also includes 1 correction related to this vendor.

Corrections
2026-03-11
Lab correction
Requester asked for a review, the lab issued an updated COA: blank correction was not accounted for in the previous analysis, resulting in an incorrect purity reading of 97.4%.
Peptide testing

Ordered Tirzepatide from BeiBangAn? Mail in a sample (US only) and let us test it.

Test my supply